Basics Revolution Medicines, Inc. IPO Date: February 13, 2020 Sector: Healthcare Industry: Biotech Market Cap: $7.57B Activated in VL: True Average Daily Range Avg Daily Range: $0.81 | 2.69% Avg Daily Range (30 D): $0.58 | 1.57% Avg Daily Range (90 D): $0.72 | 1.86% Institutional Daily Volume Avg Daily Volume: .84M Avg Daily Volume (30 D): 1.57M Avg Daily Volume (90 D): 1.58M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 4,565 Avg Inst. Trade: $3.1M Avg Inst. Trade (30 D): $3.07M Avg Inst. Trade (90 D): $4.66M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.84M Avg Closing Trade (30 D): $7.98M Avg Closing Trade (90 D): $13.83M Avg Closing Volume: 179.61K     News Aug 26, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 2025 Cant... Source: Barbara Weber, M.D. Aug 6, 2025 @ 12:25 AM Tango (TNGX) Q2 Revenue Drops 52% Source: Na Jun 27, 2025 @ 11:00 AM Tango Therapeutics Announces First Patient Dosed i... Source: Tango Therapeutics May 27, 2025 @ 1:00 PM rEvolution Appoints Brian Gabriel as Vice Presiden... Source: Globe Newswire May 12, 2025 @ 11:00 AM Tango Therapeutics Reports First Quarter 2025 Fina... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.52 $-1.31 $-1.13 Diluted EPS $-4.52 $-1.31 $-1.13 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -812.06M $ -247.79M $ -213.42M Operating Income / Loss $ -897.5M $ -264.71M $ -240.76M Cost of Revenue $ $ $ Net Cash Flow $ 127.61M $ 69.1M $ -209.51M PE Ratio